IL1F10 and psoriasis: Considering both IL-36RA and IL-38 as potential antagonists of IL-36, the majority of patients with psoriasis revealed an elevated agonist/antagonist ratio, proposing key roles of IL-36 cytokines in psoriasis and their correlation with disease severity.